Pain clinical development Archives

Lotus Supports Xgene’s Breakthrough Non-Opioid Pain Relief Clinical Trial

October 13, 2025December 23, 2024 by Ryan Speer

Lotus Supports Xgene’s Breakthrough Non-Opioid Pain Relief Trial We’re excited to share that Xgene Pharmaceutical has announced positive topline results from their late-phase trial of XG005, an innovative non-opioid treatment for post-surgical pain. Lotus Clinical Research, in collaboration with Evolution Research Group, was proud to support this multi-center, placebo-controlled, Phase 2b study across multiple U.S. … Read more

South Rampart Pharma Doses First Patient in Phase 1 Multiple Ascending Dose Trial of SPR-001

October 14, 2025August 22, 2023 by Ryan Speer

South Rampart Pharma Doses First Patient in Phase I Multiple Ascending Dose Trial of SPR-001 – SRP-001, a novel, non-opioid investigational drug that avoids the liver toxicity associated with acetaminophen, positioned to address the unmet medical need for non-toxic and non-addictive acute and chronic pain therapeutics – – Data expected in 3Q 2023 – NEW ORLEANS, Aug. 22, 2023 /PRNewswire/ … Read more

Pacira’s Exparel Shows Positive Results in Bunionectomy Clinical Study

October 14, 2025March 15, 2023 by Ryan Speer

Lotus Clinical Research worked closely with Pacira on this successful pivotal Phase 3 trial in bunionectomy, providing scientific consulting and conducting the study within our CRO and the ERG site network.